Niki BioSolutions, Inc. business relationships
Companies named in Niki BioSolutions, Inc.’s 20-F filed 2026-03-27, and public companies whose annual reports name Niki BioSolutions, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- - / 10
- AI naming
- - / 100
- Agent readiness
- - / 100
- AI adoption
- - / 100
Named in Niki BioSolutions, Inc.’s annual report 2
“October 18, 2017, the Company's subsidiary, Acticule, entered into an exclusive license agreement with Versitech Limited,” SEC filing
“Property License Agreement by and between Aptorum Therapeuctis, Aptorum, DiamiR LLC and DiamiR, dated July 14, 2025 (26) |” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.